Pitso Tebello, Sebelego Ida-Keshia, Muller Henra
Department of Clinical Sciences, Faculty of Health and Environmental Sciences Central University of Technology, Free State Bloemfontein South Africa.
Health Sci Rep. 2025 Jul 20;8(7):e70916. doi: 10.1002/hsr2.70916. eCollection 2025 Jul.
Computed tomography (CT) poses a concern in pediatric patients because of their higher sensitivity to radiation. At the time of the study, nephroblastoma was the most prevalent clinical indication for abdominal CT examinations in pediatric patients. Therefore, the aim of this study was to establish pediatric typical diagnostic reference levels (DRLs) for contrast-enhanced abdominal CT examinations of pediatric patients presenting with nephroblastoma.
The volume CT dose index (CTDI), dose-length product (DLP) and patient weight of 121 patients with nephroblastoma were collected retrospectively. Size-specific dose estimates (SSDE), CTDI and DLP were used to calculate DRL values. The SSDE was added as an additional parameter because dose estimates based on the patient's size are considered more precise. Patients were categorized into five weight groups for which DRL values were established per group. The pediatric DRL values in this study were set at the median of the data distribution.
Diagnostic reference level values were only established for two weight groups that adhered to the International Commission on Radiological Protection (ICRP) guidelines. The DRL values for CTDI ranged from 2.4 to 2.7 mGy, while the DLP ranged from 78.4 to 108 mGy.cm, and SSDE ranged from 4.9 to 5.6 mGy. The DRL values of this study were lower than the European Commission (EC) DRL values and higher than those of other international studies. The lower DRL values of this study will be used to further tailor the radiation dose to be lower than usual for optimization of the radiation dose received by pediatric patients for CT abdomen examinations.
For efficient dose optimization, clinical indication, body weight, and SSDE should be considered when developing pediatric DRL values. Future optimization strategies will benefit from adapting patient size and clinical indication as suggested and supported by the findings of this study.
计算机断层扫描(CT)对儿科患者存在风险,因为他们对辐射更为敏感。在本研究开展时,肾母细胞瘤是儿科患者腹部CT检查最常见的临床指征。因此,本研究的目的是为患有肾母细胞瘤的儿科患者的腹部增强CT检查建立儿科典型诊断参考水平(DRL)。
回顾性收集121例肾母细胞瘤患者的容积CT剂量指数(CTDI)、剂量长度乘积(DLP)和患者体重。使用特定尺寸剂量估计值(SSDE)、CTDI和DLP来计算DRL值。加入SSDE作为额外参数,因为基于患者体型的剂量估计被认为更精确。患者被分为五个体重组,并为每组确定DRL值。本研究中的儿科DRL值设定为数据分布的中位数。
仅为两个符合国际放射防护委员会(ICRP)指南的体重组建立了诊断参考水平值。CTDI的DRL值范围为2.4至2.7 mGy,而DLP的范围为78.4至108 mGy·cm,SSDE的范围为4.9至5.6 mGy。本研究的DRL值低于欧盟委员会(EC)的DRL值,高于其他国际研究的DRL值。本研究中较低的DRL值将用于进一步调整辐射剂量,使其低于常规剂量,以优化儿科患者腹部CT检查所接受的辐射剂量。
为了实现有效的剂量优化,在制定儿科DRL值时应考虑临床指征、体重和SSDE。未来的优化策略将受益于根据本研究结果所建议和支持的那样,调整患者体型和临床指征。